Quest Financial Statements From 2010 to 2024
| QPTFF Stock | USD 0.01 0.00 0.00% |
Check Quest PharmaTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest PharmaTech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Quest financial statements analysis is a perfect complement when working with Quest PharmaTech Valuation or Volatility modules.
Quest |
Quest PharmaTech Company Return On Equity Analysis
Quest PharmaTech's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Quest PharmaTech Return On Equity | -0.62 |
Most of Quest PharmaTech's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quest PharmaTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Quest PharmaTech has a Return On Equity of -0.6167. This is 97.43% lower than that of the Healthcare sector and 98.31% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 98.94% higher than that of the company.
Quest PharmaTech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Quest PharmaTech's current stock value. Our valuation model uses many indicators to compare Quest PharmaTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Quest PharmaTech competition to find correlations between indicators driving Quest PharmaTech's intrinsic value. More Info.Quest PharmaTech is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Quest PharmaTech's earnings, one of the primary drivers of an investment's value.About Quest PharmaTech Financial Statements
Quest PharmaTech stakeholders use historical fundamental indicators, such as Quest PharmaTech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Quest PharmaTech investors may analyze each financial statement separately, they are all interrelated. For example, changes in Quest PharmaTech's assets and liabilities are reflected in the revenues and expenses on Quest PharmaTech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Quest PharmaTech. Please read more on our technical analysis and fundamental analysis pages.
Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications skin penetrating active molecules for cosmetic and pharmaceutical use and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest Pharmatech is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Quest Pink Sheet
Quest PharmaTech financial ratios help investors to determine whether Quest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Quest with respect to the benefits of owning Quest PharmaTech security.